Physician profile
Michael Thomas Powers
NPI 1134150329
$457.46
in general payments reported to CMS, 2019-2025
12 companies · $64.76 in 2025
The $64.76 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.08 · 2020: $94.89 · 2021: $82.57 · 2022: $42.04 · 2023: $16.56 · 2024: $118 · 2025: $64.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $85.77 | 2020-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $72.06 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Heron Therapeutics, INC. | $69.83 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $50.12 | 2020-2024 | Iovera, Zilretta, Exparel |
| Stryker Corporation | $44.46 | 2020-2021 | |
| Bioventus LLC | $33.56 | 2022-2023 | Durolane |
| Integra Lifesciences Corporation | $26.34 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Daiichi Sankyo INC. | $22.04 | 2020 | |
| Nexus Medical Technologies LLC | $16.23 | 2025 | |
| Wright Medical Technology, INC. | $13.81 | 2019 | |
| Medline Industries LP | $12.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.